|
Welcome to datamethods
|
|
0
|
13936
|
July 12, 2018
|
|
Sequel to the odds ratio story
|
|
9
|
126
|
September 8, 2026
|
|
Bayesian predictive projection for variable selection
|
|
18
|
642
|
September 5, 2026
|
|
Cobra effect and p values
|
|
9
|
293
|
September 5, 2026
|
|
Oseltamivir (Tamiflu) again proves the need for RCT
|
|
15
|
638
|
August 31, 2026
|
|
CPMs for competing risks and multi-state models
|
|
7
|
267
|
August 26, 2026
|
|
Discussion of Assessing Heterogeneity of Treatment Effect, Estimating Patient-Specific Efficacy, and Studying Variation in Odds ratios, Risk Ratios, and Risk Differences
|
|
37
|
13503
|
August 23, 2026
|
|
Multiple imputation bootstrap validation and group lasso
|
|
5
|
182
|
August 23, 2026
|
|
Use of cpower function in Hmisc package
|
|
7
|
1802
|
August 22, 2026
|
|
Bayesian prediction when you have the whole population?
|
|
24
|
648
|
August 20, 2026
|
|
Reanalyzing MERIT design using Julia + recent numerical algorithms
|
|
5
|
370
|
August 11, 2026
|
|
Royal Statistical Society Discussion on Randomization vs Model Based Inference July 1, 2026
|
|
35
|
1542
|
August 11, 2026
|
|
Clinicians increased awareness of RCT structure
|
|
1
|
202
|
August 8, 2026
|
|
Complex decisions based on multivariate outcomes in Bayesian world
|
|
6
|
207
|
August 7, 2026
|
|
French target trial using obs data of HCQ vs not in SARS-CoV-2 infection
|
|
10
|
3542
|
August 5, 2026
|
|
Where are the exceptional responders?
|
|
12
|
1419
|
August 4, 2026
|
|
How to interpret “confidence intervals” in observational studies
|
|
259
|
5620
|
August 2, 2026
|
|
Does a Bayesian "p > 0.5" translate as "probably"?
|
|
9
|
289
|
July 30, 2026
|
|
Statistical Models Answer the Fundamental Clinical Question and Provide Clinical Trial Estimands
|
|
1
|
228
|
July 28, 2026
|
|
Combining Sensitivity and NPV in a meta-analysis
|
|
3
|
193
|
July 26, 2026
|
|
Randomized non-comparative trials: an oxymoron?
|
|
89
|
5281
|
July 10, 2026
|
|
Statistical Process Control and Experimental Design
|
|
10
|
610
|
July 8, 2026
|
|
RMS Discussions
|
|
395
|
102871
|
July 7, 2026
|
|
Cause-Agnostic RCT (CAR)
|
|
10
|
656
|
July 5, 2026
|
|
Is Repeated Bayesian Interim Analysis Consequence-Free?
|
|
18
|
1221
|
July 2, 2026
|
|
The Ethics of Underpowered Trials
|
|
11
|
334
|
July 2, 2026
|
|
Important Paper: Why almost all ML models for medicine are wrong-and what we need for evidence-based medical AI
|
|
4
|
375
|
June 22, 2026
|
|
Example of current #scicomm around observational vs prospective research
|
|
6
|
177
|
June 21, 2026
|
|
Statin-related side effects: the recent Lancet publication is biased toward false-negatives
|
|
34
|
1124
|
June 21, 2026
|
|
Modeling outcome with 95% probability
|
|
3
|
159
|
June 18, 2026
|